Prevention of post-ERCP pancreatitis.
Haber
G B
GB
D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects*; D016670:Gabexate / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D015282:Octreotide / Q000627:therapeutic use; D010195:Pancreatitis / Q000209:etiology / Q000517:prevention & control*; D012307:Risk Factors; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use; D013004:Somatostatin / Q000627:therapeutic use
D006728:Hormones; D015842:Serine Proteinase Inhibitors; D016670:Gabexate; D013004:Somatostatin; D015282:Octreotide